About: CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.47 (+5.00%)
CALC NASDAQ CalciMedica, Inc. Common Stock
CalciMedica, Inc. Common Stock share price
CALC price activity
Last Price
$1.470
Change (24hr)
0.07 USD (5.00%)
Volume
50.37K
Volume (4w avg)
-
Open
$1.40
Day Range
$1.38 - $1.53
Previous Close
$1.40
Last Trade
03 Nov, 9:00 pm GMT+0
Delayed
03 Nov, 9:00 pm GMT+0
CALC price performance
Delayed
03 Nov, 9:00 pm GMT+0
CALC details
CALC Market Signals